HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rehnmark, S. Articles by Reue, K. Search for Related Content PubMed PubMed Citation Articles by Rehnmark, S. Articles by Reue, K. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 39, 2209-2217, November 1998
Copyright © 1998 by Lipid Research, Inc.

Original Article

The fatty liver dystrophy mutant mouse: microvesicular steatosis associated with altered expression levels of peroxisome proliferator-regulated proteins

Correspondence to: Karen Reue.

Fatty liver dystrophy (fld) is an autosomal recessive mutation in mice characterized by hypertriglyceridemia and fatty liver during neonatal development. The fatty liver in fld/fld mice spontaneously resolves between the age of 14–18 days, at which point the animals develop a neuropathy associated with abnormal myelin formation in peripheral nerve. We have investigated the morphological and biochemical alterations that occur in the fatty liver of neonatal fld/fld mice. Studies at the light and electron microscopic level demonstrated the accumulation of lipid droplets and hypertrophic parenchymal cells in fld neonates, with no apparent liver pathology after resolution of the fatty liver. To better characterize the biochemical basis for the development of fatty liver in fld mice, we compared protein expression patterns in the fatty liver of fld mice and in the liver of phenotypically normal (wild-type) littermates using quantitative two-dimensional gel electrophoresis. We detected 24 proteins with significantly altered expression levels (P < 0.001) in the fld fatty liver, 15 of which are proteins that are altered in abundance by peroxisome proliferating chemicals. As these compounds characteristically elicit changes in the expression of mitochondrial and peroxisomal enzymes involved in fatty acid oxidation, we quantitated rates of fatty acid oxidation in hepatocytes isolated from fld and wild-type mice.

These studies revealed that hepatic fatty acid oxidation in fld neonates is reduced by 60% compared to wild-type littermates. In hepatocytes from adult fld mice that no longer exhibit a fatty liver, oxidation rates were similar to those in hepatocytes from age-matched wild-type mice. These findings indicate that altered expression of proteins involved in fatty acid oxidation is associated with triglyceride accumulation in the fld fatty liver.—Rehnmark, S., C. S. Giometti, B. G. Slavin, M. H. Doolittle, and K. Reue. The fatty liver dystrophy mutant mouse: microvesicular steatosis associated with altered expression levels of peroxisome proliferator-regulated proteins. J. Lipid Res. 1998. 39: 2209–2217.

Supplementary key words: triglyceride, 2-dimensional gel electrophoresis, hepatocytes

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. C. Gropler, T. E. Harris, A. M. Hall, N. E. Wolins, R. W. Gross, X. Han, Z. Chen, and B. N. Finck Lipin 2 Is a Liver-enriched Phosphatidate Phosphohydrolase Enzyme That Is Dynamically Regulated by Fasting and Obesity in Mice J. Biol. Chem., March 13, 2009; 284(11): 6763 - 6772. [Abstract] [Full Text] [PDF]

				Z. Chen, M. C. Gropler, J. Norris, J. C. Lawrence Jr, T. E. Harris, and B. N. Finck Alterations in Hepatic Metabolism in fld Mice Reveal a Role for Lipin 1 in Regulating VLDL-Triacylglyceride Secretion Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1738 - 1744. [Abstract] [Full Text] [PDF]

				W. S. Wright, K. A. Longo, V. W. Dolinsky, I. Gerin, S. Kang, C. N. Bennett, S.-H. Chiang, T. C. Prestwich, C. Gress, C. F. Burant, et al. Wnt10b Inhibits Obesity in ob/ob and Agouti Mice Diabetes, February 1, 2007; 56(2): 295 - 303. [Abstract] [Full Text] [PDF]

				J. Zhang, C. Wang, P. L. Terroni, F. R. A. Cagampang, M. Hanson, and C. D. Byrne High-unsaturated-fat, high-protein, and low-carbohydrate diet during pregnancy and lactation modulates hepatic lipid metabolism in female adult offspring Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R112 - R118. [Abstract] [Full Text] [PDF]

				R. A. Jolly, R. Ciurlionis, D. Morfitt, M. Helgren, R. Patterson, R. G. Ulrich, and J. F. Waring Microvesicular Steatosis Induced by a Short Chain Fatty Acid: Effects on Mitochondrial Function and Correlation with Gene Expression Toxicol Pathol, February 1, 2004; 32(2_suppl): 19 - 25. [Abstract] [PDF]

				H. Koutnikova, T.-A. Cock, M. Watanabe, S. M. Houten, M.-F. Champy, A. Dierich, and J. Auwerx Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR{gamma} hypomorphic mice PNAS, November 25, 2003; 100(24): 14457 - 14462. [Abstract] [Full Text] [PDF]

				K. Reue, P. Xu, X.-P. Wang, and B. G. Slavin Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene J. Lipid Res., July 1, 2000; 41(7): 1067 - 1076. [Abstract] [Full Text]

				M. Klingenspor, P. Xu, R. D. Cohen, C. Welch, and K. Reue Altered Gene Expression Pattern in the Fatty Liver Dystrophy Mouse Reveals Impaired Insulin-mediated Cytoskeleton Dynamics J. Biol. Chem., August 13, 1999; 274(33): 23078 - 23084. [Abstract] [Full Text] [PDF]